Obesity Influences Specific Genes Linked to Inflammatory Pathways in Breast Cancer

April 04, 2017
The Ohio State University Comprehensive Cancer Center  Arthur G James Cancer Hospital and Richard J Solove Research Institute

COLUMBUS, Ohio – Obesity is a known risk factor for breast and other cancers, but knowledge about the underlying biology of how, when and by what mechanism obesity influences cancer risk is limited.

New research from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) offers some of the first evidence that obesity alters in genes involved in inflammatory response (32 genes), hereditary disorders (48 genes) and other immunological diseases (42 genes).

Researchers will present their findings Tuesday, April 4, at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, D.C. 

A multidisciplinary team made of geneticists, cell biologists, medical oncologists and epidemiologists conducted a broad spectrum gene expression analysis of tissue samples from 121 healthy women with no history of breast cancer. All women were undergoing breast reduction surgery and 51 patients were clinically obese.

The team integrated DNA methylation and mRNA expression into the analysis to identify 308 genes important in the obesity/inflammation relationship. Of these, 240 were shown to have high DNA methylation (more likely to have sporadic mutations), low gene expression in obese women and 68 gene has low DNA methylation, high gene expression status. All of the affected genes were involved in diseases and disorders for inflammatory response, hereditary disorder and immunological disease.

“Different types of breast cancer could be affected differently by obesity, A more robust understanding of how obesity triggers inflammatory cancer pathways and increases breast cancer risk could help us develop better chemoprevention strategies or early prevention strategies in women at increased risk based on their weight,” says Peter Shields, MD, senior author of the AACR abstract and deputy director of the OSUCCC – James.

Future studies would be designed to understand the specific genes identified in this study among women who ultimately develop breast cancer later.

Collaborators in the study include first author Daniel Weng, PhD, Min-Ae Song, PhD, Theodore Brasky, PhD, Catalin Marian, Renny Lan of the OSUCCC-James; Adana Llanos, PhD, MPH, of Rutgers Cancer Institute, Scott Spear, MD, and Bhaskar Kallakury, MD, of Georgetown University; Jo Freudenheim, PhD, of the University of Buffalo. 


Contact Media Staff

Amanda Harper

Director of Media Relations

614-685-5420 (direct)

614-293-3737 (main)


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.


If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

Pathologists Play Critical Role in Cancer Diagnosis

Pathology has continued to advance over the past few years, and OSUCCC – James experts can now look at specific genetic and molecular changes within cancer cells – telling pathologists even more about a...

Step Up For Stefanie’s Champions an Emotional Event Celebrating Blessings

The annual Step Up for Stefanie’s Champions Walk/Run took place on April 22, 2017 and four caregivers were honored with the Champion Award. Stefanie Spielman established the Champion Award to recognize...

Multiple Myeloma Research in Progress at The James

The Multiple Myeloma Research in Progress event awarded $25,000 from the MMORE for Multiple Myeloma Research Fund to Dr. Don Benson to help support his research.